Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,707.00
Bid: 1,705.00
Ask: 1,707.00
Change: -10.00 (-0.58%)
Spread: 2.00 (0.117%)
Open: 1,738.00
High: 1,738.00
Low: 1,688.00
Prev. Close: 1,717.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

18 Nov 2014 07:00

RNS Number : 2632X
Smiths Group PLC
18 November 2014
 



 

News Release

London, 18 November 2014

For immediate release

 

 

SMITHS GROUP PLC TRADING STATEMENT

 

Smiths Group Chairman, Sir George Buckley, will refer to the following trading statement at the Company's Annual General Meeting in London today.

 

Expectations for the year remain in line with the outlook given at the full year results. Foreign exchange translation and transaction are expected to have an adverse impact of c.3% on the Group's first half headline operating profit. However, this headwind is expected to reverse during the second half if current exchange rates are maintained. More generally, as previously guided, the Group's underlying performance will be weighted towards the second half.

 

In the three months to 1 November 2014, underlying revenue and headline operating profit at Smiths Group fell as expected against the first quarter last year as growth in Smiths Medical was more than offset by declines in Smiths Detection and Smiths Interconnect. John Crane revenues and headline operating profit were broadly similar to last year's first quarter. Headline operating cash conversion was strong for the first quarter at 94%.

 

John Crane's aftermarket and first-fit rotating equipment business delivered underlying growth in revenue and operating profit in the quarter. This was offset by year-on-year declines in the upstream energy services business resulting in overall John Crane revenue and profit at a similar level to the same period last year. While this upstream business has now stabilised on a consecutive monthly basis, first quarter performance is still set against a relatively stronger prior period. The John Crane order book is expected to deliver revenue growth, although as guided at the year end, the growth rate will be below the medium-term operating range in the first half because of the headwinds in the upstream business and some manufacturing constraints affecting the aftermarket and first-fit rotating equipment business. These factors should be resolved by the end of the first half and full year margins are expected to be at the upper end of guidance. While the order book remains at near record levels, we continue to monitor the trading environment closely given wider concerns over the outlook for oil and gas capex and lower oil prices.

 

Smiths Medical saw a further improvement in underlying revenue growth driven by strong demand for infusion pumps and improving performance in its vital care business, particularly its respiratory and tracheostomy products. Headline operating profit also increased with the higher volumes and the benefit of cost saving initiatives despite the continued headwind from foreign exchange transaction impacts. We expect to see continued growth in revenue and headline operating profit in the first half and full year results.

 

Smiths Detection still faces challenging trading conditions across most of its markets reflecting continued constraints on government spending. These resulted in lower underlying revenue and headline operating profit in the first quarter. Our key priority remains to reduce costs through ongoing site rationalisation, value engineering and other productivity initiatives in order to improve profitability and combat price pressure. As previously guided, the outlook for the first half is for lower underlying revenues and margins while the full year margins are expected to improve against a weak comparator affected by one-off costs.

 

Smiths Interconnect saw declines in revenue and headline operating profit at constant currencies as the year started more slowly than expected. This reflects some spending delays by wireless telecoms customers, the timing of certain orders for test equipment with revenue benefiting the prior year and continued softness in some end markets, particularly defence. First half revenues and profitability are budgeted to be below last year. However, the second half should see some recovery against the first half reflecting normal seasonality in certain markets and the timing of benefits from growth investments.

 

Flex-Tek reported a modest increase in underlying revenue. Sales of automotive components drove growth in Fluid Management while Heat Solutions benefited from increased sales of specialty heating elements. The outlook for the full year remains positive and in line with previous guidance.

 

At 1 November, net debt was £817m, slightly increased from the £804m at 31 July 2014.

 

ENDS

 

 

This press release contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of the press release and the Company undertakes no obligation to update these forward-looking statements. Nothing in this press release should be construed as a profit forecast.

 

 

Investor Relations

Peter Durman: +44 (0)20 7808 5535

 

Media Relations

Colin McSeveny: +44 (0)20 7808 5534

Anthony Cardew - Cardew Group: +44 (0)20 7930 0777

 

Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs around 23,000 people in over 50 countries. For more information visit www.smiths.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFFMFAWFLSEEF
Date   Source Headline
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20243:35 pmRNSTotal Voting Rights
3rd Jun 202410:00 amRNSDirectorate Change
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSSmiths Group 3rd Quarter Results
16th May 20249:30 amRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20244:45 pmRNSDirector/PDMR Shareholding
1st May 20243:30 pmRNSTotal Voting Rights
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:00 amRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20244:30 pmRNSTotal Voting Rights
27th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.